GAMMA Investing’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

GAMMA Investing’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-42	Closed	-$403	–	3915
2024 Q4	$403	Buy	+42	New	+$219	﹤0.01%	3608

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMMA Investing's PSTX Position: Q1 2025 in Review

GAMMA Investing sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 42 shares — an estimated $403 sold.

GAMMA Investing first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $403 in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

GAMMA Investing reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
GAMMA Investing sold 42 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $403.
GAMMA Investing first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
GAMMA Investing's Poseida Therapeutics, Inc. Common Stock position peaked at $403 in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on GAMMA Investing's 13F filing for Q1 2025, filed 7 Apr 2025.